Zhi-Jun Pei
Overview
Explore the profile of Zhi-Jun Pei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Liu X, Yuan L, Gao Y, Ming X, Zhang Y, Zhang Y, et al.
J Transl Med
. 2023 Aug;
21(1):574.
PMID: 37626419
Background: This study investigated the correlation between the expression of DARS2 and metabolic parameters of F-FDG PET/CT, and explored the potential mechanisms of DARS2 affecting the proliferation and glycolysis of...
12.
Liu X, Zeng J, Zhang Y, Zhang Y, Gao Y, Liu C, et al.
Am J Cancer Res
. 2023 Apr;
13(3):818-834.
PMID: 37034224
Overexpression of DARS2 may enhance the progression of hepatocellular carcinoma (HCC). However, there are few extensive reports on DARS2 function in lung adenocarcinoma (LUAD). The differential expression of DARS2 was...
13.
Zeng D, Chang C, Liu X, Gao Y, Wang Y, Pei Z
Front Med (Lausanne)
. 2022 Nov;
9:1024008.
PMID: 36388941
Herein, we report a case of retroperitoneal clear cell carcinoma (RCCC) with an unknown primary site that was confirmed pathology. A 46-year-old man presented with low-grade fever, hyperhidrosis, and nightly...
14.
Zhang Y, Zeng J, Liu X, Gao Y, Kui X, Liu X, et al.
Front Endocrinol (Lausanne)
. 2022 Oct;
13:1013238.
PMID: 36299451
Background: The targeted therapy for lung cancer relies on prognostic genes and requires further research. No research has been conducted to determine the effect of endothelin-converting enzyme 2 (ECE2) in...
15.
Liu X, Gao Y, Kui X, Liu X, Zhang Y, Zhang Y, et al.
J Transl Med
. 2022 Oct;
20(1):450.
PMID: 36195940
Background: The aim of this study was to determine the expression and function of heterogeneous nuclear ribonucleoprotein R (HNRNPR) in esophageal carcinoma (ESCA), the correlation between its expression and F-fluorodeoxyglucose...
16.
Liu X, Liu C, Zeng J, Zeng D, Chen Y, Tan F, et al.
Front Pharmacol
. 2022 Oct;
13:1010879.
PMID: 36188614
NPM1 is highly expressed in a variety of solid tumors and promotes tumor development. However, there are few comprehensive studies on NPM1 analysis in gastrointestinal cancer. We used bioinformatics tools...
17.
Kui X, Gao Y, Liu X, Zeng J, Yang J, Zhou L, et al.
Front Oncol
. 2022 Aug;
12:809847.
PMID: 35957868
Background: Solute carrier family 17 member 9 (SLC17A9) encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. SLC17A9 is involved in...
18.
Liu X, Kui X, Gao Y, Chen X, Zeng J, Liu X, et al.
Front Genet
. 2022 Apr;
13:835265.
PMID: 35401696
YTHDF1 is highly expressed in multiple tumors and affects tumor progression. However, there are only a few comprehensive studies on the analysis of YTHDF1 in esophageal cancer. We analyzed YTHDF1...
19.
Liu X, Yang J, Zeng J, Chen X, Gao Y, Kui X, et al.
Front Cell Dev Biol
. 2022 Apr;
10:853596.
PMID: 35399515
Overexpression of solute carrier family 2 member 1 (SLC2A1) promotes glycolysis and proliferation and migration of various tumors. However, there are few comprehensive studies on SLC2A1 in colorectal cancer (CRC)....
20.
Liu X, Wu R, Wan H, Chen Y, Tan F, Zeng D, et al.
Front Med (Lausanne)
. 2022 Mar;
9:840795.
PMID: 35355611
A 62-year-old female patient with pathologically confirmed left lung small cell neuroendocrine carcinoma. The patient was referred to our positron emission tomography (PET)/CT center to look for possible metastatic diseases....